Sort
39,280 grants matching “leukemia”
Chemically Controlled Assembly of Therapuetic Protein Nanostrctures
$348,922Carston R. Wagner · University Of Minnesota · R01 · FY2007 · CA
EM Cyrstallography Core
$348,909Mark Jay Yeager · University Of Utah · P50 · FY2007 · GM
Glioblastoma - Molecular Analysis for Clinical Trials
$348,886Paul S Mischel · University Of California Los Angeles · R01 · FY2006 · NS
The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia
$348,844Rene Opavsky · University Of Florida · R01 · FY2018 · CA
Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL
$348,844Michael W Deininger · University Of Utah · R01 · FY2021 · CA
A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia
$348,844Carol S Lim · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Drug-Free Macromolecular Therapeutics
$348,844Jindrich N. Kopecek · University Of Utah · R01 · FY2020 · CA
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
$348,844Jonathan D. Licht · University Of Florida · R01 · FY2018 · CA
Drug-Free Macromolecular Therapeutics
$348,844Jindrich N. Kopecek · University Of Utah · R01 · FY2021 · CA
Drug-Free Macromolecular Therapeutics
$348,844Jindrich N. Kopecek · University Of Utah · R01 · FY2023 · CA
A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia
$348,844Carol S Lim · University Of Utah · R01 · FY2021 · CA
Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia
$348,844Michael W Deininger · University Of Utah · R01 · FY2020 · CA
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
$348,844Jonathan D. Licht · University Of Florida · R01 · FY2017 · CA
The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia
$348,844Rene Opavsky · University Of Florida · R01 · FY2017 · CA
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
$348,844Jonathan D. Licht · University Of Florida · R01 · FY2016 · CA
AML1 AND ITS FUSION PROTEINS IN HEMATOPOIESIS AND LEUKEMIA
$348,824Beth Israel Deaconess Medical Center · P01 · FY2000 · CA
CHARACTERIZATION OF TEL, A NEW LEUKEMOGENIC ETS PROTEIN
$348,824Beth Israel Deaconess Medical Center · P01 · FY2000 · CA
FUNCTIONS OF ELF-1 AND A NOVEL ETS FACTOR NERF IN B CELLS
$348,824Beth Israel Deaconess Medical Center · P01 · FY2000 · CA
ROLE OF ETS FACTOR PU.1 AND C/EBP-ALPHA IN MYELOPOIESIS
$348,824Beth Israel Deaconess Medical Center · P01 · FY2000 · CA
Control of Calcium Entry Signals in B Cells
$348,812Donald L Gill · Temple Univ Of The Commonwealth · R01 · FY2008 · AI
Harnessing Alloreactivity
$348,785Fuchs Ephraim · Johns Hopkins University · P01 · FY2009 · CA
Genetic Basis of Polycythemia Vera
$348,771Josef T Prchal · Icahn School Of Medicine At Mount Sinai · P01 · FY2007 · CA
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
$348,768Rolf Muller · Biofluidica, Inc · R44 · FY2018 · CA
Prebiotics to Optimize the Microbiota and Improve Outcomes of AllogeneicHematopoietic Stem Cell Transplantation
$348,750Anthony Sung · University Of Kansas Medical Center · R01 · FY2024 · HL
Polyglutamine Toxicity in Drosophila
$348,750State University Of New York At Buffalo · R01 · FY2001 · NS